SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-000253
Filing Date
2020-01-06
Accepted
2020-01-06 17:29:22
Documents
5
Period of Report
2020-01-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 40058
2 ex5-1.htm EX-5.1 11844
3 ex5-1_001.jpg GRAPHIC 3779
4 ex10-1.htm EX-10.1 311556
5 ex99-1.htm EX-99.1 12749
  Complete submission text file 0001493152-20-000253.txt   382705
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 20511024
SIC: 2835 In Vitro & In Vivo Diagnostic Substances